Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Therapeutic Hypothermia May Reduce Heart Attack Survival

By HospiMedica International staff writers
Posted on 19 Oct 2016
A new study suggests that use of therapeutic hypothermia (TH) in patients with in-hospital cardiac arrest is associated with a lower likelihood of survival to hospital discharge.

Researchers at Duke University (Durham, NC, USA), Saint Luke's Mid America Heart Institute (Kansas City, MO, USA), and other institutions identified 26,183 patients successfully resuscitated from an in-hospital cardiac arrest at 355 U.S. More...
hospitals between March 1, 2002, and December 31, 2014. The researchers examined induction of TH for all cardiac arrests, as well as separately for nonshockable (asystole and pulseless electrical activity) and shockable (ventricular fibrillation and pulseless ventricular tachycardia) cardiac arrests.

The primary outcome of the study was survival to hospital discharge, with a secondary outcome of favorable neurological survival. The results showed that only 6% of the patients were treated with TH; after adjustment, TH was associated with lower in-hospital survival (27.4% versus 29.2%), and this association was similar for both nonshockable and shockable cardiac arrest rhythms. TH was also associated with lower rates of favorable neurological survival for the overall cohort and for both rhythm types. The study was published on October 4, 2016, in JAMA.

“When follow-up was extended to one year, there remained no survival advantage with therapeutic hypothermia treatment. Collectively, these findings do not support current use of therapeutic hypothermia for patients with in-hospital cardiac arrest,” concluded lead author Paul Chan, MD, of Saint Luke's Mid America Heart Institute, and colleagues. “These observational findings warrant a randomized clinical trial to assess efficacy of therapeutic hypothermia for in-hospital cardiac arrest.”

Therapeutic cooling is among the most potent interventions for hypoxic-ischemic injury, a broad constellation of conditions ranging from cardiac and respiratory arrest to carbon monoxide (CO) and other poisonous gas exposure, and appears to limit tissue damage by reducing oxygen metabolism and inflammation, while maintaining cell membrane integrity. TH is used for patients following both out-of-hospital and in-hospital cardiac arrest, but trials on its efficacy for the in-hospital setting did not exist, and comparative effectiveness data are therefore limited.

Related Links:
Duke University
Saint Luke's Mid America Heart Institute

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.